Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on November 12, 2025
November 12, 2025
Growing Awareness of Drug-Resistant Infections Fuels Cephalosporin Market | To Set $16.87 Billion
Indeterminate
EIN Presswire
November 12, 2025
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Indeterminate
GlobeNewswire
November 12, 2025
Anteris Announces Results for the Third Quarter of 2025
Indeterminate
GlobeNewswire
November 12, 2025
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 12, 2025
BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results
Indeterminate
GlobeNewswire
November 12, 2025
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Indeterminate
GlobeNewswire
November 12, 2025
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Indeterminate
GlobeNewswire
November 12, 2025
Inventiva announces launch of public offering
Indeterminate
GlobeNewswire
November 12, 2025
Inventiva annonce le lancement d'une offre au public
Indeterminate
GlobeNewswire
November 12, 2025
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 12, 2025
LogicMark, Inc. Announces Third Quarter 2025 Results
Indeterminate
GlobeNewswire
November 12, 2025
MaxCyte Announces Planned CFO Transition in 2026
Indeterminate
GlobeNewswire
November 12, 2025
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 12, 2025
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Indeterminate
GlobeNewswire
November 12, 2025
Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 12, 2025
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
Indeterminate
GlobeNewswire
November 12, 2025
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
Indeterminate
GlobeNewswire